Siga Technologies Shares Outstanding 2006-2019 | SIGA

Siga Technologies shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Siga Technologies Annual Shares Outstanding
(Millions of Shares)
2018 83
2017 79
2016 57
2015 54
2014 53
2013 52
2012 52
2011 54
2010 45
2009 37
2008 35
2007 33
2006 28
2005 25
Siga Technologies Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 82
Q2 2019 82
Q1 2019 82
Q4 2018 83
Q3 2018 83
Q2 2018 81
Q1 2018 79
Q4 2017 79
Q3 2017 79
Q2 2017 79
Q1 2017 79
Q4 2016 57
Q3 2016 54
Q2 2016 54
Q1 2016 54
Q4 2015 54
Q3 2015 54
Q2 2015 54
Q1 2015 54
Q4 2014 53
Q3 2014 54
Q2 2014 53
Q1 2014 53
Q4 2013 52
Q3 2013 53
Q2 2013 52
Q1 2013 52
Q4 2012 52
Q3 2012 52
Q2 2012 52
Q1 2012 52
Q4 2011 54
Q3 2011 52
Q2 2011 55
Q1 2011 50
Q4 2010 45
Q3 2010 46
Q2 2010 44
Q1 2010 43
Q4 2009 37
Q3 2009 38
Q2 2009 37
Q1 2009 36
Q4 2008 35
Q3 2008 35
Q2 2008 35
Q1 2008 34
Q4 2007 33
Q3 2007 34
Q2 2007 41
Q1 2007 33
Q4 2006 28
Q3 2006 28
Q2 2006 27
Q1 2006 27
Q4 2005 25
Q3 2005 25
Q2 2005 25
Q1 2005 25
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.412B $0.477B
SIGA Technologies Inc. is applying viral and bacterial genomics and sophisticated computational modeling in the design and development of novel products for the prevention and treatment of serious infectious diseases, with an emphasis on products for biological warfare defense. SIGA believes that it is a leader in the development of pharmaceutical agents and vaccines to fight potential biowarfare pathogens. With broad technology platforms in both vaccines and antibiotics, SIGA's product development programs emphasize the increasingly serious problem of drug resistant bacteria. In addition to smallpox, SIGA has antiviral programs targeting other Category A pathogens, including arenaviruses, dengue virus, and the filoviruses.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $64.930B 10.26
Zoetis (ZTS) United States $57.313B 34.28
Astellas Pharma (ALPMY) Japan $31.713B 15.84
Eisai (ESALY) Japan $20.263B 39.07
UCB SA (UCBJF) Belgium $15.697B 0.00
Merck (MKGAF) Germany $15.483B 21.13
Grifols, S.A (GRFS) Spain $15.250B 19.46
Neurocrine Biosciences (NBIX) United States $10.382B 490.13
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $9.043B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Ionis Pharmaceuticals (IONS) United States $8.171B 16.55
Jazz Pharmaceuticals (JAZZ) Ireland $7.858B 10.04
Sage Therapeutics (SAGE) United States $7.667B 0.00
Catalent (CTLT) United States $7.478B 30.42
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.263B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $5.014B 18.02
Arrowhead Pharmaceuticals (ARWR) United States $4.788B 109.78
United Therapeutics (UTHR) United States $4.060B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.428B 12.53
FibroGen (FGEN) United States $3.285B 96.54
Nektar Therapeutics (NKTR) United States $3.221B 0.00
Evotec AG (EVTCY) Germany $3.079B 50.38
PTC Therapeutics (PTCT) United States $2.766B 0.00
Portola Pharmaceuticals (PTLA) United States $2.270B 0.00
Xencor (XNCR) United States $2.140B 65.05
Heron Therapeutics (HRTX) United States $2.089B 0.00
Zogenix (ZGNX) United States $2.022B 0.00
Tilray (TLRY) Canada $2.003B 0.00
Corcept Therapeutics (CORT) United States $1.938B 23.56
Ironwood Pharmaceuticals (IRWD) United States $1.803B 57.50
Pacira Pharmaceuticals (PCRX) United States $1.791B 52.99
USANA Health Sciences (USNA) United States $1.568B 16.73
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.238B 20.42
Radius Health (RDUS) United States $1.135B 0.00
ArQule (ARQL) United States $1.021B 0.00
Endo (ENDP) Ireland $1.009B 1.85
Theravance Biopharma (TBPH) Cayman Islands $0.991B 0.00
Karyopharm Therapeutics (KPTI) United States $0.980B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.949B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.909B 6.20
Aerie Pharmaceuticals (AERI) United States $0.874B 0.00
Organogenesis Holdings (ORGO) United States $0.754B 0.00
TherapeuticsMD (TXMD) United States $0.702B 0.00
Translate Bio (TBIO) United States $0.639B 0.00
Collegium Pharmaceutical (COLL) United States $0.638B 0.00
Flexion Therapeutics (FLXN) United States $0.628B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.573B 0.00
Concordia (CXRXF) Canada $0.552B 0.00
ImmunoGen (IMGN) United States $0.521B 0.00
ChemoCentryx (CCXI) United States $0.505B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.465B 56.38
Aptorum Group (APM) Hong Kong, SAR China $0.457B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.449B 0.00
Ardelyx (ARDX) United States $0.445B 0.00
OptiNose (OPTN) United States $0.440B 0.00
Dermira (DERM) United States $0.439B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.394B 16.98
Recro Pharma (REPH) United States $0.383B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.380B 0.00
Akebia Therapeutics (AKBA) United States $0.378B 0.00
Lannett Co Inc (LCI) United States $0.363B 4.23
Harpoon Therapeutics (HARP) United States $0.360B 0.00
DURECT (DRRX) United States $0.360B 0.00
Indivior (INVVY) United States $0.355B 1.28
Innate Pharma SA (IPHYF) France $0.340B 0.00
Molecular Templates (MTEM) United States $0.300B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.287B 0.00
Rafael Holdings (RFL) United States $0.282B 0.00
GlycoMimetics (GLYC) United States $0.264B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.224B 0.00
Xeris Pharmaceuticals (XERS) United States $0.216B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.208B 0.00
Calithera Biosciences (CALA) United States $0.208B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.207B 0.00
KalVista Pharmaceuticals (KALV) United States $0.203B 0.00
Nature's Sunshine Products (NATR) United States $0.188B 32.50
Avadel Pharmaceuticals (AVDL) Ireland $0.180B 0.00
Jounce Therapeutics (JNCE) United States $0.170B 2.28
Concert Pharmaceuticals (CNCE) United States $0.162B 0.00
Taiwan Liposome (TLC) Taiwan $0.162B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.158B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.139B 0.00
Aquestive Therapeutics (AQST) United States $0.136B 0.00
Ocular Therapeutix (OCUL) United States $0.135B 0.00
Redhill Biopharma (RDHL) Israel $0.132B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.130B 0.00
MEI Pharma (MEIP) United States $0.130B 0.00
CV Sciences (CVSI) United States $0.122B 0.00
CannTrust Holdings (CTST) Canada $0.119B 0.00
IMV INC (IMV) Canada $0.116B 0.00
Cardiome Pharma (CORV) Canada $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.096B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.090B 0.00
MediWound (MDWD) Israel $0.085B 0.00
Majesco Entertainment (PTE) United States $0.083B 0.00
Neos Therapeutics (NEOS) United States $0.077B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.075B 22.41
Otonomy (OTIC) United States $0.074B 0.00
Aclaris Therapeutics (ACRS) United States $0.073B 0.00
Pharmaxis (PXSLY) Australia $0.068B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.066B 0.00
SCYNEXIS (SCYX) United States $0.065B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.064B 0.00
Generex Biotechnology (GNBT) United States $0.062B 0.00
Infinity Pharmaceuticals (INFI) United States $0.060B 0.00
Champions Oncology (CSBR) United States $0.060B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.059B 0.00
Natural Alternatives (NAII) United States $0.059B 14.59
Genocea Biosciences (GNCA) United States $0.058B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.057B 0.00
Medicure (MCUJF) Canada $0.056B 0.00
RENEURON GP (RNUGF) United Kingdom $0.054B 0.00
AgeX Therapeutics (AGE) United States $0.054B 0.00
Novan (NOVN) United States $0.053B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.050B 0.00
Nivalis Therapeutics (ALPN) United States $0.048B 0.00
Capnia (SLNO) United States $0.048B 0.00
ElectroCore (ECOR) United States $0.046B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.045B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.043B 0.00
CTI BioPharma (CTIC) United States $0.042B 0.00
Forward Pharma (FWP) Denmark $0.040B 0.00
Mast Therapeutics (SVRA) United States $0.037B 0.00
Mannatechorporated (MTEX) United States $0.037B 0.00
Opexa Therapeutics (ACER) United States $0.033B 0.00
India Globalization Capital (IGC) United States $0.031B 0.00
Iterum Therapeutics (ITRM) Ireland $0.030B 0.00
Biomerica (BMRA) United States $0.030B 0.00
Jaguar Animal Health (JAGX) United States $0.030B 0.00
Bio-Path Holdings (BPTH) United States $0.028B 0.00
IsoRay (ISR) United States $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
PharmAthene (ALT) United States $0.023B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
Melinta Therapeutics (MLNT) United States $0.020B 0.00
Heat Biologics (HTBX) United States $0.018B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Shineco (TYHT) China $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.013B 0.00
Flex Pharma (SLRX) United States $0.012B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Lipocine (LPCN) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Vical (BBI) United States $0.007B 0.00
Achieve Life Sciences (ACHV) United States $0.007B 0.00
VAXART, INC (VXRT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
RXi Pharmaceuticals (PHIO) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Hemispherx BioPharma (AIM) United States $0.001B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00